Unlock new possibilities in hormone replacement therapy with Exemestane--a powerful, steroidal aromatase inhibitor that optimally targets hormone receptor-positive breast cancer in postmenopausal women, achieving superior outcomes over conventional treatments.
Mechanism
Exemestane employs a revolutionary method called suicide inhibition, irreversibly binding to the aromatase enzyme, thereby halting estrogen production from androgens. This dramatic reduction in estrogen levels (by over 85-95%) is crucial for effectively managing hormone-dependent breast cancer. Its unique steroidal structure also provides mild androgenic effects, ensuring a favorable safety profile for bone density and lipid levels.
Research
Groundbreaking clinical trials like the Intergroup Exemestane Study (IES) and MA.27 have revealed that transitioning to exemestane after 2-3 years of tamoxifen treatment significantly boosts breast cancer-free survival rates while maintaining bone and cardiovascular health.
Synergies
Explore the synergy of exemestane with complementary therapies tailored to optimize your hormone balance and bone health. Ben IQ will analyze YOUR labs and goals to find the perfect combination.
Trade-Offs
While exemestane offers distinct benefits for select patient populations, it's crucial to weigh factors like cost, possible side effects, and contraindications. Your personalized approach requires YOUR specific data.